Junshi Biosciences and Coherus Announce Presentation of Positive Results from CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer, at March ASCO Plenary Series

– Toripalimab plus chemotherapy met both primary endpoint of progression free survival and prespecified secondary endpoint of overall survival compared to chemotherapy alone – – Data support the use of…

Prevasio Announces Oscar Marquez as New CEO

Expansion of management team strengthens leadership, prepares company for further success MENLO PARK, Calif., March 15, 2022 (GLOBE NEWSWIRE) — Prevasio, Inc., a startup providing next-generation tools to democratize Cloud…